A-1 Limited Signs Long-Term Nitric Acid Supply Agreement and Advances Stock Split and Bonus Issue

A-1 Limited informs the stock exchanges that it has entered a new long-term supply agreement for concentrated nitric acid. The tri-partite deal involves Gujarat Narmada Valley Fertilizers & Chemicals Limited, Solar Industries India Limited with its group companies, and A-1 Limited. The committed quantity is 10,000 metric tonnes. Supplies are scheduled between November 2025 and March 2026.

Under this supply structure, Gujarat Narmada Valley Fertilizers & Chemicals Limited will produce and sell concentrated nitric acid. Solar Industries India Limited and its group entities will buy and consume the material. A-1 Limited will operate as dealer in the chain. Extra quantities, over the committed volume, may be supplied if all parties agree.

The nitric acid arrangement is classified as a long-term supply contract and is expected to strengthen volume visibility for all participants. It is designed to reinforce A-1 Limited’s role as a dependable distribution and marketing partner for large specialty chemical companies. The company states that promoters and the promoter group have no interest in this agreement, and it does not qualify as a related-party transaction.

Earlier in November, A-1 Limited sought shareholder consent through postal ballot and electronic voting for several corporate actions. These included a bonus share issue, a stock split, an increase in authorised share capital, amendments to the memorandum of association, and investments in A-1 Sureja Industries. During the board meeting on November 14, 2025, directors cleared all proposals, including a 10:1 stock split and a 3:1 bonus issue. Record and allotment dates are still pending.

The Board of Directors proposed issuing bonus equity shares in a 3:1 ratio to eligible shareholders on the record date, subject to approval through postal ballot. The Board also supported splitting each fully paid equity share of face value Rs. 10 into ten fully paid equity shares of face value Re. 1. After the subdivision, the number of equity shares would increase to 46 crore, each carrying a face value of Re. 1.

The plan also includes raising the authorised share capital of A-1 Limited. Authorised capital is proposed to rise from Rs. 20 crore to Rs. 46 crore, aligning with the higher number of shares after the split and bonus issue. Key terms of these actions are summarised below.

Item	Details
Bonus ratio	3 bonus equity shares for every 1 share held
Stock split	From Rs. 10 to Re. 1 face value per share
Total equity shares post split	46 crore shares of Re. 1 each
Authorised capital	Increase from Rs. 20 crore to Rs. 46 crore
Board approval date	November 14, 2025

A-1 Limited states that e-voting and postal ballot for these resolutions will open on November 22, 2025, and will close on December 21, 2025. Results are scheduled for publication on or before December 23, 2025. All actions remain conditional on shareholder approval through this process.

Business expansion linked to A-1 Limited long-term supply agreement

Alongside the capital-related steps, the Board has cleared changes to the company’s object clause. The revised objects will support growth in importing and distributing sports equipment. They will also permit A-1 Limited to build a sourcing, supply, and contract manufacturing business and to manufacture pharmaceutical products aimed at global markets.

A-1 Limited reports a five-decade track record in industrial acid trading, distribution, and logistics, which supports its current role in India’s chemical value chain. The company is working towards becoming a multi-vertical green enterprise by 2028, combining clean mobility offerings with low-emission chemical operations. With diversified revenue streams, scalable manufacturing, and rising institutional interest, management positions A-1 Limited as a prepared mid-cap ESG-focused player.